Healthcare Business Valuation in 2026: How Medical Practices and Healthcare Companies Are Valued

Healthcare businesses are valued like other businesses, until the regulations and the reimbursement dynamics take over. A medical practice with the same EBITDA as a generic service business can be worth half as much or twice as much depending on payer mix, compliance posture, referral structure, and whether it sits in a sector PE-backed platforms are actively rolling up. This page covers how healthcare businesses get valued, the typical ranges by type, and the factors that actually move the number.

We are CT Acquisitions, a buy-side M&A advisory firm. With the buyer-paid model, sellers pay no advisory fee, the buyer pays at closing. This is general orientation, not legal, regulatory, or appraisal advice; healthcare transactions require specialized counsel and (for high-scrutiny valuations) a credentialed appraiser with healthcare experience. For related context, see our CPA business valuation, how to value a small business, and private equity value creation pages.

Typical valuation ranges by healthcare business type

These ranges vary widely with the specifics; a credentialed appraiser or a healthcare-experienced sell-side advisor narrows them to your situation.

The regulatory factors that move healthcare valuations

• Payer mix. Commercial insurance reimburses more than Medicare, which reimburses more than Medicaid. A practice with 70% commercial payers is worth meaningfully more than the same practice at 70% Medicaid. Payer-contract strength and rate trends matter as much as the mix.
• Stark Law and the Anti-Kickback Statute (AKS). Federal laws governing physician self-referral and inducements. A business with referral relationships, ownership structures, or compensation arrangements that don’t fit a Stark exception or AKS safe harbor carries serious risk; buyers diligence this hard, and a violation can be a deal-killer or a major price hit.
• Corporate practice of medicine (CPOM). Many states restrict who can own a medical practice (generally only licensed physicians), which shapes deal structure, PE buyers typically use a ‘friendly PC’ / management services organization (MSO) structure. A non-compliant existing structure is a problem.
• HIPAA and data security. Compliance posture, prior breaches, business associate agreements, all diligenced. A breach history or weak posture discounts the value.
• Accreditation and licensure. Joint Commission, AAAHC, CARF (for behavioral health), CHAP/ACHC (for home health), in good standing, with a clean survey history, supports the value; deficiencies discount it.
• Certificate of Need (CON). In CON states, the regulatory barrier to entry can be valuable (incumbents are protected) but also constrains growth.
• Reimbursement-rate trends. Buyers price in known and anticipated rate changes (Medicare fee schedule updates, payer contract renewals, site-of-service shifts).
• Provider retention. Healthcare businesses depend on physicians, nurses, therapists, clinicians, and their retention post-close is a top diligence concern. Employment agreements, non-competes (where enforceable), and retention/equity structures matter.
• PE-backed consolidation activity in the specialty. Sectors where platforms are actively rolling up, dermatology, GI, ophthalmology, behavioral health, home health, urgent care, dental, command premium multiples because there’s competitive buyer demand.

What healthcare buyers actually pay for

• Recurring, predictable revenue from strong payer contracts, multi-year service agreements, or large patient panels with high retention.
• A clean regulatory house, Stark/AKS-compliant arrangements, HIPAA compliance, accreditation in good standing, no open surveys or investigations.
• Provider depth and retention, the business runs without the founding physician/owner doing everything; key providers will stay.
• Favorable payer mix and rate trends, commercial-heavy, with stable or improving reimbursement.
• Scalability, de novo expansion potential, ancillary-service growth, additional locations.
• Documented compliance and quality systems, policies, training records, audit history, outcomes data.
• A growth thesis the buyer can execute, more providers, more locations, more ancillary revenue, better payer contracts.

When you need a credentialed healthcare valuation

You need a credentialed appraiser with healthcare experience for: estate and gift tax involving practice ownership; divorce where a practice is a marital asset; physician-partner buyouts and shareholder disputes; ESOP formation; transaction fairness opinions; and any situation where the value must withstand IRS, court, or regulatory scrutiny, and where ‘fair market value’ has a specific regulatory meaning (Stark and AKS require that compensation and asset purchases be at fair market value, so a defensible FMV opinion is often part of the transaction itself, not just the seller’s diligence). For simply selling a healthcare business, a healthcare-experienced sell-side advisor’s indicative valuation is the starting point; the actual price is set by what qualified buyers (PE-backed platforms, strategic systems, larger groups) will pay through a competitive process. With the buyer-paid model, the advisory fee comes from the buyer at closing, not the seller.

Related: CPA business valuation, how to value a small business, how to calculate a business valuation, private equity value creation, buyer-paid broker alternative, certified business valuation.

The five pillars of how CT Acquisitions works

Frequently asked questions

How is a healthcare business valued?

Using the same three approaches as any business, income (discounted cash flow), market (normalized SDE or EBITDA times a comparable-transaction multiple), and asset (adjusted net asset value), but with healthcare-specific multiples and heavy regulatory weighting. The factors that move the value most: payer mix (commercial vs Medicare/Medicaid), regulatory compliance (Stark Law, Anti-Kickback Statute, HIPAA, state corporate-practice-of-medicine rules), referral patterns, provider retention, accreditation, reimbursement-rate trends, and whether the sector has active PE-backed consolidation. A credentialed appraiser with healthcare experience or a healthcare-aware sell-side advisor narrows the range to your situation.

What multiple does a medical practice sell for?

Roughly 0.5x-1.0x annual revenue or 2x-4x SDE for a solo or very small physician practice; 3x-6x+ EBITDA for a group or specialty practice; 5x-9x+ EBITDA for an ambulatory surgery center. Dental practices: roughly 0.6x-1.0x+ revenue or 3x-6x+ EBITDA. The multiple expands with payer mix (commercial-heavy is worth more), provider depth and retention, scale and de novo potential, clean regulatory compliance, and whether the specialty is one PE-backed platforms are actively consolidating (dermatology, GI, ophthalmology, orthopedics, dental, etc.).

What’s the highest-multiple healthcare sector?

Among the highest are behavioral and mental health / addiction treatment (roughly 8x-14x+ EBITDA in active consolidation), home health and hospice (roughly 7x-11x+ EBITDA), healthcare IT and revenue-cycle-management businesses with strong recurring revenue (roughly 5x-12x+ EBITDA), and ambulatory surgery centers (roughly 5x-9x+ EBITDA). These sectors combine demographic tailwinds, scalability, and active PE-backed consolidation, which creates competitive buyer demand and pushes multiples up. The specifics, payer mix, accreditation, provider retention, growth runway, still drive where a particular business lands in the range.

How do Stark Law and the Anti-Kickback Statute affect a healthcare business sale?

Significantly. Stark Law (physician self-referral) and the Anti-Kickback Statute (inducements for referrals) are federal laws that buyers diligence intensely. Referral relationships, ownership structures, and compensation arrangements that don’t fit a Stark exception or AKS safe harbor carry serious risk, a violation can be a deal-killer or a major price hit. Also, Stark and AKS require that asset purchases and compensation be at fair market value, so a defensible FMV opinion is often part of the transaction structure itself, not just the seller’s diligence. Healthcare transactions require specialized regulatory counsel.

What is the corporate practice of medicine and how does it affect valuation?

Corporate practice of medicine (CPOM) doctrine, in effect in many states, generally restricts ownership of a medical practice to licensed physicians, preventing non-physician corporations from owning practices directly. It shapes deal structure: PE buyers and other non-physician acquirers typically use a ‘friendly PC’ / management services organization (MSO) structure, where a physician-owned professional corporation owns the practice and an MSO provides management services under a management agreement. A non-compliant existing structure is a problem buyers will need to fix, and it affects how the deal can be done and therefore the value.

Do I need a special appraiser for a healthcare business valuation?

For high-scrutiny purposes, yes, you want a credentialed appraiser (ASA, ABV, or CVA) with specific healthcare valuation experience, because healthcare valuations turn on regulatory factors (Stark/AKS fair-market-value requirements, payer-mix analysis, accreditation, CON, reimbursement trends) that a generalist appraiser may not handle well. For estate/gift tax, divorce, partner buyouts, ESOPs, and transaction fairness opinions, a healthcare-experienced credentialed appraiser is essential. For simply selling a healthcare business, a healthcare-experienced sell-side advisor’s indicative valuation is the starting point.

Why is payer mix so important in healthcare valuation?

Because reimbursement rates differ dramatically by payer, commercial insurance pays more than Medicare, which pays more than Medicaid, so two practices with the same patient volume can have very different revenue and EBITDA depending on their payer mix. A commercial-heavy practice is worth meaningfully more than the same practice at 70% Medicaid. Buyers also scrutinize payer-contract strength (how favorable the rates are, how long the contracts run) and rate trends (anticipated Medicare fee schedule changes, payer contract renewals). Improving payer mix and locking in favorable contracts before a sale can meaningfully increase the multiple.

How do I sell a healthcare business for the best price?

Improve and document the things buyers pay for: shift toward a commercial-heavy payer mix and lock in favorable contracts; get the regulatory house clean (Stark/AKS-compliant arrangements, HIPAA compliance, accreditation in good standing, no open surveys or investigations); build provider depth and retention so the business doesn’t depend on the founding owner; demonstrate a scalability thesis (de novo locations, ancillary services); document compliance and quality systems; and run a competitive process that reaches the right buyers, PE-backed platforms in your specialty, strategic systems, larger groups. With the buyer-paid model, the advisory fee comes from the buyer at closing, not the seller.

Related research

• Free Business Valuation Tool, your business is worth in 90 seconds
• The Business Broker Alternative Guide (national pillar)
• Business Brokers by State, with a free alternative
• The Complete Guide to Selling Your Business in 2026
• What’s My Business Worth? Founder’s Valuation Guide
• Who Buys These Companies? Buyer Types Explained
• How to Sell to Private Equity, A Founder’s Walkthrough
• Owner’s Pre-Exit Checklist, 90 Days Before You List
• CT Commentary, Founder & M&A Insights